Lineage, Inc. logo

Lineage, Inc. (LINE)

Market Closed
16 Oct, 08:00 PM
NASDAQ (NGS) NASDAQ (NGS)
$
33. 28
-0.83
-2.4333%
$
7.58B Market Cap
- P/E Ratio
0.94% Div Yield
890,700 Volume
- Eps
$ 34.11
Previous Close
Add Transaction
Day Range
33.2 34.54
Year Range
31.33 45.75
Want to track LINE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Lineage, Inc. (LINE) Q1 2026 Earnings Call Transcript

Lineage, Inc. (LINE) Q1 2026 Earnings Call Transcript

Lineage, Inc. (LINE) Q1 2026 Earnings Call Transcript

Seekingalpha | 5 months ago
Lineage, Inc. (LINE) Q1 FFO Beat Estimates

Lineage, Inc. (LINE) Q1 FFO Beat Estimates

Lineage, Inc. (LINE) came out with quarterly funds from operations (FFO) of $0.78 per share, beating the Zacks Consensus Estimate of $0.7 per share. This compares to FFO of $0.86 per share a year ago.

Zacks | 5 months ago
All You Need to Know About Lineage, Inc. (LINE) Rating Upgrade to Buy

All You Need to Know About Lineage, Inc. (LINE) Rating Upgrade to Buy

Lineage, Inc. (LINE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zacks | 6 months ago
Lineage: Cold Storage REIT Still Undervalued Thanks To Near-Term Headwinds

Lineage: Cold Storage REIT Still Undervalued Thanks To Near-Term Headwinds

Lineage remains a buy, supported by strong fundamentals and a leading position in temperature-controlled warehouse REITs despite near-term macro headwinds. LINE delivered robust 2025 AFFO growth of 22.7% ($865M), but expects a ~14.7% per-share AFFO decline in 2026 amid weak occupancy and macro uncertainty. Dividend yield stands at 5.15% with a sustainable payout ratio, and management targets $110M run-rate cost savings over 3-5 years.

Seekingalpha | 7 months ago
Lineage, Inc. (LINE) Reports Q4 Earnings: What Key Metrics Have to Say

Lineage, Inc. (LINE) Reports Q4 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Lineage, Inc. (LINE) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Zacks | 7 months ago
Lineage, Inc. (LINE) Beats Q4 FFO Estimates

Lineage, Inc. (LINE) Beats Q4 FFO Estimates

Lineage, Inc. (LINE) came out with quarterly funds from operations (FFO) of $0.83 per share, beating the Zacks Consensus Estimate of $0.73 per share. This compares to FFO of $0.83 per share a year ago.

Zacks | 7 months ago
Lineage Vs. Americold: Why Tech Leadership Makes LINE The Superior REIT

Lineage Vs. Americold: Why Tech Leadership Makes LINE The Superior REIT

Lineage (LINE) stands out as the cold storage industry leader, leveraging proprietary technology and geographic diversification to drive structural cost advantages over peers. LINE's LinOS platform is a significant competitive advantage, expected to boost margins and productivity, though rollout delays present near-term execution risk. Industry oversupply is being absorbed, with demand now outpacing new supply; LINE's 6% dividend yield is well covered and supported by a conservative payout ratio.

Seekingalpha | 9 months ago
Lineage: Cold-Storage REIT Getting Too Hot To Ignore

Lineage: Cold-Storage REIT Getting Too Hot To Ignore

Lineage is reiterated as a buy, trading at a significant discount to NAV and intrinsic value estimates, with strong recovery potential. LINE offers a ~6.1% dividend yield at a sustainable ~64% payout ratio, with plenty of room for increases or buybacks. Despite macro headwinds and lowered guidance, LINE continues to expand, leveraging its scale for future accretive growth and even industry consolidation.

Seekingalpha | 10 months ago
Lineage, Inc. (LINE) Discusses Warehouse Productivity Initiatives and Digital Strategy Including LinOS Platform Prepared Remarks Transcript

Lineage, Inc. (LINE) Discusses Warehouse Productivity Initiatives and Digital Strategy Including LinOS Platform Prepared Remarks Transcript

Lineage, Inc. (LINE) Discusses Warehouse Productivity Initiatives and Digital Strategy Including LinOS Platform Prepared Remarks Transcript

Seekingalpha | 10 months ago
Lineage Cell Therapeutics: OpRegen Makes It A Viable Speculative Buy

Lineage Cell Therapeutics: OpRegen Makes It A Viable Speculative Buy

Lineage Cell Therapeutics' OpRegen is partnered with Genentech/Roche. In my view, this is their main value driver in GA dry AMD. Looking ahead, their GAlette Phase 2a trial is enrolling, which could further validate the rest of their portfolio's potential. LCTX's pipeline also has OPC1 for spinal cord injury. Its preclinical R&D includes ANP1, PNC1, RND1, and ILT1.

Seekingalpha | 11 months ago
Lineage, Inc. (LINE) Q3 2025 Earnings Call Transcript

Lineage, Inc. (LINE) Q3 2025 Earnings Call Transcript

Lineage, Inc. ( LINE ) Q3 2025 Earnings Call November 5, 2025 8:00 AM EST Company Participants Ki Bin Kim W. Lehmkuhl - CEO, President & Director Robert Crisci - Chief Financial Officer Conference Call Participants Caitlin Burrows - Goldman Sachs Group, Inc., Research Division Michael Goldsmith - UBS Investment Bank, Research Division Steve Sakwa - Evercore ISI Institutional Equities, Research Division Craig Mailman - Citigroup Inc., Research Division Ronald Kamdem - Morgan Stanley, Research Division Michael Carroll - RBC Capital Markets, Research Division Alexander Goldfarb - Piper Sandler & Co., Research Division Omotayo Okusanya - Deutsche Bank AG, Research Division Greg McGinniss - Scotiabank Global Banking and Markets, Research Division Daniel Guglielmo - Capital One Securities, Inc., Research Division Vikram Malhotra - Mizuho Securities USA LLC, Research Division Blaine Heck - Wells Fargo Securities, LLC, Research Division Michael Lewis Samir Khanal - BofA Securities, Research Division Michael Mueller - JPMorgan Chase & Co, Research Division Todd Thomas - KeyBanc Capital Markets Inc., Research Division Nicholas Thillman - Robert W.

Seekingalpha | 11 months ago
Lineage, Inc. (LINE) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Lineage, Inc. (LINE) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for Lineage, Inc. (LINE) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks | 11 months ago
Loading...
Load More